TD Cowen Initiates Coverage on Verona Pharma (NASDAQ:VRNA)
Equities researchers at TD Cowen initiated coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report) in a report issued on Monday, Marketbeat reports. The firm set a “buy” rating and a $100.00 price target on the stock. TD Cowen’s price target would indicate a potential upside of 36.59% from the company’s current price. […]
Equities researchers at TD Cowen initiated coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report) in a report issued on Monday, Marketbeat reports. The firm set a “buy” rating and a $100.00 price target on the stock. TD Cowen’s price target would indicate a potential upside of 36.59% from the company’s current price. […]
